Nonlinear Relationship Between Chromatin Accessibility and Estradiol-regulated Gene Expression
Overview
Authors
Affiliations
Chromatin accessibility is central to basal and inducible gene expression. Through ATAC-seq experiments in estrogen receptor-positive (ER+) breast cancer cell line MCF-7 and integration with multi-omics data, we found estradiol (E2) induced chromatin accessibility changes in a small number of breast cancer-relevant E2-regulated genes. As expected, open chromatin regions associated with E2-inducible gene expression showed enrichment of estrogen response element (ERE) and those associated with E2-repressible gene expression were enriched for ERE, PBX1, and PBX3. While a significant number of open chromatin regions showed pioneer factor FOXA1 occupancy in the absence of E2, E2-treatment further enhanced FOXA1 occupancy suggesting that ER-E2 enhances chromatin occupancy of FOXA1 to a subset of E2-regulated genes. Surprisingly, promoters of 80% and enhancers of 60% of E2-inducible genes displayed closed chromatin configuration both in the absence and presence of E2. Integration of ATAC-seq data with ERα ChIP-seq data revealed that ~40% ERα binding sites in the genome are found in chromatin regions that are not accessible as per ATAC-seq. Such ERα binding regions were enriched for binding sites of multiple nuclear receptors including ER, ESRRB, ERRγ, COUP-TFII (NR2F2), RARα, EAR2 as well as traditional pioneer factors FOXA1 and GATA3. Similar data were also obtained when ERα ChIP-seq data were integrated with MNase-seq and DNase-seq data sets. In summation, our results reveal complex mechanisms of ER-E2 interaction with nucleosomes. Notably, "closed chromatin" configuration as defined by ATAC-seq or by other techniques is not necessarily associated with lack of gene expression and technical limitations may preclude ATAC-seq to demonstrate accessibility of chromatin regions that are bound by ERα.
Single-Cell Multiomics Analysis of Early Wound Response Programs in the Mouse Corneal Epithelium.
Lu Z, Ye J, Li J, Liang J, Zhou M, Hu Q Invest Ophthalmol Vis Sci. 2025; 66(3):9.
PMID: 40042873 PMC: 11892537. DOI: 10.1167/iovs.66.3.9.
Jefferson W, Wang T, Padilla-Banks E, Williams C Nucleic Acids Res. 2024; 52(18):10897-10917.
PMID: 39166489 PMC: 11472041. DOI: 10.1093/nar/gkae714.
Nasif D, Laurito S, Real S, Branham M Breast Cancer Res Treat. 2024; 207(1):91-101.
PMID: 38702584 DOI: 10.1007/s10549-024-07343-5.
Nair V, Pincas H, Smith G, Zaslavsky E, Ge Y, Amper M Cell Genom. 2024; 4(6):100421.
PMID: 38697122 PMC: 11228891. DOI: 10.1016/j.xgen.2023.100421.
Detection of new pioneer transcription factors as cell-type-specific nucleosome binders.
Peng Y, Song W, Teif V, Ovcharenko I, Landsman D, Panchenko A Elife. 2024; 12.
PMID: 38293962 PMC: 10945518. DOI: 10.7554/eLife.88936.